160256-75-7

Basic information

• Product Name: DIBENZYL 2,2'-IMINOBIS(ETHYLCARBAMATE)
• Synonyms: N,N''-DI-BENZYLOXYCARBONYL-DIETHYLENETRIAMINE;N,N''-DI-Z-DIETHYLENETRIAMINE;Z-EDA-EDA-Z;DIBENZYL 2,2'-IMINOBIS(ETHYLCARBAMATE);Dibenzyl (azanediylbis(ethane-2,1-diyl))dicarbamate;N,N''-Di-Z-diethylenetriamine≥ 97% (HPLC)
• CAS NO: 160256-75-7
• Molecular Formula: C₂₀H₂₅N₃O₄
• Molecular Weight: 371.43
• Mol File: 160256-75-7.mol

Chemical Properties

• Melting Point: 70-74 °C
• Appearance: /
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• BRN: 7083538
• CAS DataBase Reference: DIBENZYL 2,2'-IMINOBIS(ETHYLCARBAMATE)(CAS DataBase Reference)
• NIST Chemistry Reference: DIBENZYL 2,2'-IMINOBIS(ETHYLCARBAMATE)(160256-75-7)
• EPA Substance Registry System: DIBENZYL 2,2'-IMINOBIS(ETHYLCARBAMATE)(160256-75-7)

Safety Data

• Hazard Codes: Xi,N
• Statements: 37/38-41-50
• Safety Statements: 26-39-61
• RIDADR: UN 3077 9/PG 3
• WGK Germany: 3
• Hazardous Substances Data: 160256-75-7(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
DIBENZYL 2,2'-IMINOBIS(ETHYLCARBAMATE) is used as a building block for the creation of chemical libraries. It is particularly useful in introducing a protected 2,2'-iminodi(ethylamine) scaffold, which can be further modified or functionalized to develop a wide range of compounds with diverse applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, DIBENZYL 2,2'-IMINOBIS(ETHYLCARBAMATE) is used as a key intermediate in the synthesis of various drug candidates. Its ability to introduce a protected 2,2'-iminodi(ethylamine) scaffold allows for the development of novel compounds with potential therapeutic applications.
Used in Research and Development:
DIBENZYL 2,2'-IMINOBIS(ETHYLCARBAMATE) is also utilized in research and development settings, where it aids in the exploration of new chemical reactions and the synthesis of innovative molecules. Its role in introducing a protected 2,2'-iminodi(ethylamine) scaffold makes it a valuable tool for scientists working on the design and development of new chemical entities.

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 111-40-0 3-azapentane-1,5-diamine 
• 28170-07-2 benzyl phenyl carbonate 
• 100-51-6 benzyl alcohol 
• 22129-07-3 N-benzyloxycarbonylimidazole 
• 5532-86-5 benzyl cyanoformate 

Downstream Products

• 1145787-27-4 N'-uracil-3-ylaminocarbonylmethyl-N,N''-dicarbobenzoxydiethylenetriamine 
• 192636-10-5 N,N-Bis-(2-benzyloxycarbonylamino-ethyl)-succinamic acid 
• 1610625-57-4 N,N′′-bis(carbobenzyloxy)-N′-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]bis(2-aminoethyl)amine 
• 1571097-22-7 dibenzyl (((tert-butoxycarbonyl)azanediyl)bis(ethane-2,1-diyl))dicarbamate 
• 1333174-03-0 2-N,N-bis(2-CBz-aminoethyl)amino-4,6-bis(N-propylamino)-1,3,5-triazine 
• 1333174-04-1 2-N,N-bis(2-CBz-aminoethyl)amino-4,6-dichloro-1,3,5-triazine 
• 1245573-65-2 C₃₇H₄₆BF₂N₅O₄ 
• 872462-43-6 (5-benzyloxycarbonylamino-6-(bis-(2-benzyloxycarbonylaminoethyl)-amino)-hexyl)-carbamic acid tert-butyl ester 
• 1020857-61-7 4-benzyloxycarbonylamino-5-(bis-(2-benzyloxycarbonylaminoethyl)-amino)-pentanoic acid benzyl ester 
• 872462-22-1 (4-(2-benzyloxycarbonylamino-3-(bis-(2-benzyloxycarbonylaminoethyl)-amino)-propyl)-phenoxy)-acetic acid benzyl ester 
• 1083175-01-2 tert-butyl (2S)-5-[bis(2-{[(benzyloxy)carbonyl]amino}ethyl)amino]-2-{bis[(tert-butoxy)carbonyl]amino}pentanoate 
• 174700-73-3 [bis[2-(benzyloxycarbonylamino)ethyl]amino]acetic acid tert-butyl ester 

Relevant articles and documents

Cationic lipid molecule, and application thereof in nucleic acid delivery

The present invention discloses a cationic lipid molecule, and an application thereof in nucleic acid delivery. The structural formula of the cationic lipid molecule is represented by formula i. The invention further provides a cationic liposome, a lipid compound, a reagent, a kit, a preparation and a medicinal composition based on the cationic lipid molecule. The cationic lipid molecule has the advantages of simple synthesis process and good stability, and the cationic liposome has a high efficiency (characterized by high transfection efficiency) and a low toxicity, is stable and uniform, is easy to prepare, and can be used for transferring various cell lines. The cationic lipid molecule has excellent transitivity, and can efficiently deliver active substances (such as exemplary siRNA) omto cells (such as exemplary lung cancer cells), tissues and organs to achieve efficient regulation of the active substances. The problem that the toxicity and the transfer efficiency of cationic liposome existing in the prior art are low is solved.

FREE-STANDING NON-FOULING POLYMERS, THEIR COMPOSITIONS, AND RELATED MONOMERS

Free-standing non-fouling polymers and polymeric compositions, monomers and macromonomers for making the polymers and polymeric compositions, objects made from the polymers and polymeric compositions, and methods for making and using the polymers and polymeric compositions.

Single-molecule imaging of platinum ligand exchange reaction reveals reactivity distribution

Single-molecule fluorescence microscopy provided information about the real-time distribution of chemical reactivity on silicon oxide supports at the solution-surface interface, at a level of detail which would be unavailable from a traditional ensemble technique or from a technique that imaged the static physical properties of the surface. Chemical reactions on the surface were found to be uncorrelated; that is, the chemical reaction of one metal complex did not influence the location of a future chemical reaction of another metal complex.

Design, synthesis and evaluation of novel uracil acetamide derivatives as potential inhibitors of Plasmodium falciparum dUTP nucleotidohydrolase

The ubiquitous enzyme dUTP nucleotidohydrolase (dUTPase) catalyses the hydrolysis of dUTP to dUMP and can be considered as the first line of defence against incorporation of uracil into DNA. Inhibition of this enzyme results in over-incorporation of uraci

INSULIN DERIVATIVES CONJUGATED WITH STRUCTURALLY WELL DEFINED BRANCHED POLYMERS

Insulin conjugated with structurally well defined, bifurcated and trifurcated polymers can be use by pulmonary delivery for systemic absorption through the lungs to reduce or eliminate the need for administering other insulins by injection.

DERIVATIVES OF INSULINOTROPIC AGENTS CONJUGATED WITH STRUCTURALLY WELL DEFINED BRANCHED POLYMERS

Novel GLP-1 conjugated with structurally well defined polymers and their therapeutically use.

Selective synthesis of carbamate protected polyamines using alkyl phenyl carbonates

Utilising alkyl phenyl carbonates, an economical, practical and versatile method for selective Boc, Cbz and Alloc protection of polyamines has been developed. This method allows Boc, Cbz and Alloc protection of primary amines in the presence of secondary amines by reaction of the polyamines with the alkyl phenyl carbonates. Also, this method allows mono carbamate protection of simple symmetrical aliphatic α,ω-alkanediamines in high yields with respect to the diamine. Finally, the method allows selective carbamate protection of a primary amine located on a primary carbon in the presence of a primary amine located on a secondary or a tertiary carbon in excellent yields.

Pseudopolyrotaxanes

PCT No. PCT/EP97/03344 Sec. 371 Date Dec. 30, 1998 Sec. 102(e) Date Dec. 30, 1998 PCT Filed Jun. 25, 1997 PCT Pub. No. WO98/01163 PCT Pub. Date Jan. 15, 1998The invention relates to new metal complex-containing or iodine-containing benzene derivatives tha

Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes

Cascade polymer complexes that contain a) complexing ligands of general formula I in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand for a direct bond or a cascade reproduction